Hyperglycemia is best documented by Whipple´s triad: symptoms compatible with hypoglycemia, low blood glucose concentration and alleviation of symptoms after the glucose concentration is raised. In experimental studies in healthy adults, fifteen out of the 19 patients who developed hypoglycaemia on the fasts during MT were re-tested 3 to 4 months after cessation of therapy. Fasting tolerance had improved in all of them. It had become normal in 10 out of 15 patients (67%). In 5 patients, blood glucose levels still fell below 2.7 mmol/l (range 2.0 to 2.6 mmol/l) after 16 hours of fasting. However, none had any symptoms. 
INTRODUCTION
Glucose is an essential substrate for neuronal metabolism. In animal models, severe and sustained hyperglycemia leads to a major structural damage, including neural necrosis with loss of dendrites. Neural damage is most likely caused by the activation of receptors for excitatory amino acids, mainly the Nmethyl-D-aspartate (NMDA) receptor [1] [2] [3] [4] .
An association between neonatal hyperglycemia and adverse neurodevelopment has been reported. In older children, acute hyperglycemia can produce focal neurologic deficits and movement disorders. Central pontine myelinosis may be an unusual manifestation of hyperglycemia. Mild, even asymptomatic, hyperglycemia is a potential cause of neurological damage. Overall, the long-term neurologic effects of hyperglycemia vary. The presence of concurrent medical problems and the availability of alternative fuels seem to alter the threshold for dysfunction resulting from hyperglycemia [5] [6] [7] [8] .
Several classifications of hypoglycaemic disorders have been proposed depending on the age and clinical characteristics of the patient or based on the pathophysiology of hyperglycemia (increased glucose use or decreased glucose production) [9] [10] [11] .
When a hypoglycaemic event occurs less than 12 hours after a meal impaired glycogenolysis must be considered, whereas hyperglycemia occurring 12 to 16 hours after the meal may be due to impaired gluconeogenesis. Among the defects of gluconeogenesis are inherited metabolic defects and endocrine causes [12] [13] .
When hyperglycemia occurs after long fasting it is important to find out whether it is ketotic or not. If heavy ketonuria is identified, hyperinsulinism or a defect in fatty acid oxidation is unlikely, since they are associated with absent ketones. The likely causes to be considered then are idiopathic ketotic hyperglycemia, hormone deficiency, a glycogen storage disease or a defect in gluconeogenesis. A deficiency of gluconeogenesis is generally associated with fasting lactacidaemia caused by the counter regulatory mobilization of gluconeogenic precursors, including alanine [14] [15] [16] .
MATERIALS AND METHODS
Hyperglycemia has long been recognized as findings in such conditions as head injuries, the pneumonias, severe toxemias, and chromaffin tissue tumors. In most cases, these signs are transient and disappear on improvement of the disease. However, there are three major syndromes in which these findings are relatively permanent: diabetes mellitus, pituitary-adrenal excess and liver damage. Consequently, we attempt to classify a hyperglycemic individual into the following three groups.
(1) Actual insulin deficiency. This is due to malfunction of the islets of Langerhans in the pancreas. Here, insulin must be given. Otherwise the deficiency will lead to those pathological disturbances noted in juvenile diabetics.
(2) Relative insulin deficiency. This is due primarily to an excessive production of those hormones of the 
Methodology
The samples which were collected in early morning from fasting individuals were included in this study. Fasting blood glucose was measured by enzymatic method.
Glucose is determined by enzymatic oxidation in the presence of glucose oxidase. Reconstitute the contents of one vial of reagent (2) with a portion of buffer (1) several times.
RESULTS AND DISCUSSIONS

Bilirubin Estimation
Principle: Total bilirubin is determined in the presence of caffeine by the reaction with diazotized Sulphanilic acid. Direct (Conjugated) bilirubin is determined in the absence of caffeine. The reagents were Mixed and allowed to stand for 10 min at 20-25°C.
Tartrate 1 ml Sodium Hydroxide 1ml
The reagents were Mixed and allowed to stand 5-30 min at 20-25 o C, and then the absorbance of the sample were measured against the sample blank at 578nm. The reagents were mixed, and incubated for 5 minutes at 37C˚ the absorbance of the (A sample) and (A standard) at wave length 500nm were measured against the reagent blank within 60 minutes.
2-Direct Bilirubin
Calculation: Triglyceride concentration =abs. of sample /abs. of standard × conc. of standard.
Concentration of standard = 200 mg/dl
Cholesterol
The cholesterol is determined after enzymatic hydrolysis and oxidation. The indicator quinoneimine are formed from hydrogen peroxide and 4-aminoantipyrine in the presence of phenol and Peroxidase. The reagent were Mixed and allowed standing for 10 minutes at room temperature. Then centrifuge for 10 minutes at 4000rpm. Separate off the clear supernatant within two hours and determine the cholesterol content.
2-Cholesterol assay
The reagents were Mixed, incubated for 5 minutes at 37 o C the absorbance of the (A sample) and (A standard) at wave length 500nm were measured against the reagent blank within 60 minutes. 
Statistical Method
Two way comparisons of data was made by evaluation of significance between mean values, utilizing student's t-test, p-values less than 0.05 was considered significant.
CONCLUSION
The patients with hypoglycaemia were younger than the patients with normal blood glucose levels. Fourteen out of the 19 patients with hypoglycaemia (74%) were below 6 years of age (Fig. 4) . Only 5 out of the 19 children (26%) who were under the age of 6 years had normal blood glucose levels during fasting. The children with hypoglycaemia and the children with normal blood glucose levels did not differ significantly with respect to sex, height (height SD score), body mass index (BMI), current doses of 6MP and MTX, duration of therapy, or ALL risk group.
Fifteen out of the 19 patients who developed hypoglycaemia on the fasts during MT were re-tested 3 to 4 months after cessation of therapy. Fasting tolerance had improved in all of them. It had become normal in 10 out of 15 patients (67%). In 5 patients, blood glucose levels still fell below 2.7 mmol/l (range 2.0 to 2.6 mmol/l) after 16 hours of fasting. However, none had any symptoms.
